glp 1 chronic kidney disease GLP-1 receptor agonists and next-generation metabolic hormone therapies in Glucagon-Like Peptide-1 Receptor Agonists for

Lowering your blood pressure can lower your risk of heart attacks and strokes

The parent hormone binds melanocortin receptors, especially MC1R, which appears on skin cells, immune cells, and more

In December 2025, Wegovy received conditional authorization for the treatment of non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition

According to their respective PK profiles, exenatide BID and lixisenatide can be categorized as short-acting agents (each has a half-life of 35 h) compared with the long-acting agents liraglutide, exenatide LAR, albiglutide, and dulaglutide, which have half-lives ranging from 12 h to several days [16]